- The Centers for Disease Control and Prevention (CDC) estimate that at least 15% of the US adult population (about 37 million people) have chronic kidney disease, especially those people with high blood pressure and/or diabetes;
- African-American, Native American, and Hispanic communities are especially hard hit;
- The common ways to detect CKD include clinical history (excessive thirst and urination, weight loss, fatigue), blood tests for metabolic wastes such as urea and creatinine, and urinalysis;
- Current ways of testing miss up to 90% of CKD Stage 1 and Stage 2 (early-stage CKD) patients – when these patients could be helped with medical and behavior therapies which may slow or stop progression to more severe (Stages 3, 4, and 5) CKD
- By the time CKD is detected, it may be serious and can be progressive; our Rametrix® Molecular Urinalysis System offers an innovative approach to detection and management of CKD
